Immutep (IMMP) EBIT (2011 - 2026)

Immutep (IMMP) has reported EBIT for 15 consecutive years, with -$57.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBIT changed N/A year-over-year to -$57.9 million; the trailing twelve-month figure through Jun 2026 stood at -$120.9 million (changed N/A YoY), and the FY2026 full-year result was -$57.9 million, down 47.02% from the prior year.
• EBIT slipped to -$57.9 million in Q2 2026 per IMMP's latest filing, from -$17.3 million in the prior quarter.
• Across five years, EBIT topped out at -$14.1 million in Q4 2022 and bottomed at -$57.9 million in Q2 2026.
• Historically, EBIT has averaged -$26.5 million across 4 years, with a median of -$20.8 million in 2022.
• The sharpest annual moves came in 2022 and 2024: EBIT decreased 5.54% in 2022, then declined 14.74% in 2024.
• Over 4 years, EBIT stood at -$14.1 million in 2022, then declined by 6.9% to -$15.1 million in 2023, then fell by 14.74% to -$17.3 million in 2024, then tumbled by 235.03% to -$57.9 million in 2026.
• According to Business Quant data, EBIT over the past three periods registered -$57.9 million, -$17.3 million, and -$30.7 million for Q2 2026, Q4 2024, and Q2 2024 respectively.